EUVIMEDEUVIMED entdecken
Open Access

Mechanical Thrombectomy and Catheter-Directed Lysis in Treating Intermediate-Risk Pulmonary Embolization: 30-Day Outcome

Nicolas W Shammas iD, William Sharis, George Mankarious, Yoshitha Inala, Morgan J Janes, Gail Shammas, Sue Jones-Miller, Cara Voelliger

International Journal of Angiology · 2025-09 · 34 (03) · 169-175

DOI: 10.1055/a-2577-2385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Angiology, online erschienen am 02.05.2025. Verfasst von Nicolas W Shammas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Research, Midwest Cardiovascular Research Foundation, Davenport, Iowa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intermediate risk pulmonary embolism (IRPE) is defined as dilatation of the right ventricular (RV) and evidence of myocardial necrosis with stable hemodynamics in the setting of acute PE. The differences in performance among the various devices in treating IRPE remain unclear. We reviewed consecutive patients treated at 2 medical centers between January 1, 2019, and December 31, 2022, using PMC devices (FlowTriever [Inari Medical] or Ekos [Boston Scientific]). Demographics, clinical, procedural variables, in-hospital complications, and 30-day outcomes were recorded from patients' medical records. Descriptive analyses were performed. The study's primary endpoint was the mean change in the RV/LV ratio. Safety endpoints included procedural complications 30-day mortality and major bleeding. 97 consecutive patients (43 FlowTriever, 54 Ekos) were included. The mean age was 64.16 ± 13.37 years. When compared with pretreatment, PMC reduced significantly the RV/LV ratio (0.55 ± 0.49, 95% CI: 0.40, 0.71, p < 0.0001) and PA pressures (17.98 ± 14.72 mm Hg, 95% CI:10.88, 25.07, p < 0.0001) with no differences seen between the FlowTriever and Ekos. At 30-day, all-cause mortality and major bleeding were 5.2 and 7.2%, respectively, and were similar between the FlowTriever and Ekos, respectively (4.7% vs. 5.6% (p = 0.935) and 7.0% vs. 7.4% (p = 0.935)). The Ekos, however, had a shorter procedure time, and less fluoroscopy and contrast use. PMC devices reduced significantly the RV/LV ratio and PA pressures when compared with the baseline. No differences were seen between the FlowTriever and Ekos. Thirty-day mortality and major bleeding were statistically similar between the two devices.

Schlagwörter

Stichwörter der Autor:innen

intermediate-risk pulmonary embolusmajor bleedingmechanical thrombectomyultrasound-assisted lysis

Autor:innen und Institutionen

  • Division of Cardiovascular Research, Midwest Cardiovascular Research Foundation, Davenport, Iowa.

ORCID-Profile: Nicolas W Shammas

Zitieren

APA

Shammas, N. W., Sharis, W., Mankarious, G., Inala, Y., Janes, M. J., Shammas, G., Jones-Miller, S., & Voelliger, C. (2025). Mechanical Thrombectomy and Catheter-Directed Lysis in Treating Intermediate-Risk Pulmonary Embolization: 30-Day Outcome. International Journal of Angiology, 34(03), 169-175. https://doi.org/10.1055/a-2577-2385

Vancouver

Shammas NW, Sharis W, Mankarious G, Inala Y, Janes MJ, Shammas G, et al. Mechanical Thrombectomy and Catheter-Directed Lysis in Treating Intermediate-Risk Pulmonary Embolization: 30-Day Outcome. International Journal of Angiology. 2025;34(03):169-175. doi:10.1055/a-2577-2385

BibTeX
@article{Shammas2025,
  author = {Shammas, Nicolas W and Sharis, William and Mankarious, George and Inala, Yoshitha and Janes, Morgan J and Shammas, Gail and Jones-Miller, Sue and Voelliger, Cara},
  title = {Mechanical Thrombectomy and Catheter-Directed Lysis in Treating Intermediate-Risk Pulmonary Embolization: 30-Day Outcome},
  journal = {International Journal of Angiology},
  year = {2025},
  volume = {34},
  number = {03},
  pages = {169--175},
  doi = {10.1055/a-2577-2385}
}
Kostenlos starten →